Patents by Inventor Hyang Ran Lim

Hyang Ran Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND COMPOSITIONS FOR TREATING NEURONAL DEATH OR NEUROLOGICAL DYSFUNCTION
    Publication number: 20120301551
    Abstract: The present invention relates to 2-hydroxy-alkylamino-benzoic acid derivatives and to a combination of cell necrosis inhibitor and lithium, process for the preparation of the derivatives or the combination, pharmaceutical formulation containing the derivatives or the combination, and use of the derivatives or the combination by either concomitant or sequential administration for improvement of treatment of neuronal death or neurological dysfunction. The derivatives and the combination of the present invention are useful for treating neurological diseases, such as amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), spinal muscular atrophy, Alzheimer's disease, Parkinson's disease, Huntington's disease, stroke, traumatic brain injury or spinal cord injury; and for treating ocular diseases such as glaucoma, diabetic retinopathy or macular degeneration.
    Type: Application
    Filed: June 22, 2012
    Publication date: November 29, 2012
    Applicant: Neurotech Pharmaceuticals Co., Ltd.
    Inventors: Byoung Joo GWAG, Young Ae Lee, Jin Hee Shin, Sung Ig Cho, Jae Sung Noh, Jae Young Cho, Ki Won Kim, Hyang Ran Lim, Jae Keun Lee, Han Yeol Byun, Sun Young Ko, Sun Joo Son, Sun Mi Park
  • COMPOUNDS AND COMPOSITIONS FOR TREATING NEURONAL DEATH OR NEUROLOGICAL DYSFUNCTION
    Publication number: 20090149542
    Abstract: The present invention relates to 2-hydroxy-alkylamino-benzoic acid derivatives and to a combination of cell necrosis inhibitor and lithium, process for the preparation of the derivatives or the combination, pharmaceutical formulation containing the derivatives or the combination, and use of the derivatives or the combination by either concomitant or sequential administration for improvement of treatment of neuronal death or neurological dysfunction. The derivatives and the combination of the present invention are useful for treating neurological diseases, such as amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), spinal muscular atrophy, Alzheimer's disease, Parkinson's disease, Huntington's disease, stroke, traumatic brain injury or spinal cord injury; and for treating ocular diseases such as glaucoma, diabetic retinopathy or macular degeneration.
    Type: Application
    Filed: December 9, 2008
    Publication date: June 11, 2009
    Applicant: Neurotech Pharmaceuticals Co., Ltd.
    Inventors: Byoung Joo GWAG, Young Ae Lee, Jin Hee Shin, Sung Ig Cho, Jae Sung Noh, Jae Young Cho, Ki Won Kim, Hyang Ran Lim, Jae Keun Lee, Han Yeol Byun, Sun Young Ko, Sun Joo Son, Sun Mi Park